14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PETX
Delisted

Aratana Therapeutics Stock Price (Quote)

$4.92
+0 (+0%)
At Close: Sep 20, 2019

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 20th Sep 2019 PETX stock ended at $4.92. During the day the stock fluctuated 0% from a day low at $4.92 to a day high of $4.92.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Aratana Therapeutics prices

Date Open High Low Close Volume
Sep 28, 2016 $9.08 $9.48 $9.04 $9.39 732 000
Sep 27, 2016 $8.94 $9.21 $8.92 $9.10 618 400
Sep 26, 2016 $9.28 $9.33 $8.90 $8.93 601 100
Sep 23, 2016 $9.40 $9.71 $9.22 $9.28 763 400
Sep 22, 2016 $9.22 $9.49 $9.13 $9.41 827 000
Sep 21, 2016 $9.14 $9.22 $8.83 $9.13 542 900
Sep 20, 2016 $9.21 $9.33 $9.07 $9.12 325 900
Sep 19, 2016 $9.24 $9.42 $9.07 $9.17 433 000
Sep 16, 2016 $9.08 $9.35 $9.07 $9.19 512 800
Sep 15, 2016 $8.94 $9.16 $8.89 $9.16 588 700
Sep 14, 2016 $8.87 $9.10 $8.81 $8.99 561 200
Sep 13, 2016 $9.15 $9.20 $8.67 $8.80 657 600
Sep 12, 2016 $8.91 $9.22 $8.60 $9.21 702 700
Sep 09, 2016 $9.79 $9.86 $9.10 $9.13 753 700
Sep 08, 2016 $9.27 $9.90 $9.22 $9.80 1 122 200
Sep 07, 2016 $9.33 $9.33 $9.04 $9.28 770 700
Sep 06, 2016 $9.00 $9.25 $8.96 $9.25 680 900
Sep 02, 2016 $9.04 $9.04 $8.71 $8.81 377 800
Sep 01, 2016 $8.92 $9.03 $8.73 $8.92 503 500
Aug 31, 2016 $9.17 $9.19 $8.62 $8.87 808 300
Aug 30, 2016 $9.40 $9.44 $9.14 $9.23 630 100
Aug 29, 2016 $9.08 $9.43 $9.01 $9.36 845 400
Aug 26, 2016 $9.09 $9.19 $8.90 $9.07 602 900
Aug 25, 2016 $9.00 $9.28 $8.94 $9.04 861 600
Aug 24, 2016 $9.41 $9.44 $8.94 $9.07 1 157 900
Click to get the best stock tips daily for free!

About Aratana Therapeutics

Aratana Therapeutics Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. Its product portfolio includes various therapeutic candidates consisting of small molecule pharmaceuticals and large molecule biologics that target various opportunities in serious medical conditions in pets. The company develops AT-001, a prostag... PETX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT